Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
POLDIP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
C15orf59 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGFBP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCNH6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTCH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MUC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC100631378 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TFRC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MLLT10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEMP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALDH7A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FARP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on